Oxy-inflammation in hyperbaric oxygen therapy applications
Open Access
- 20 January 2025
- journal article
- Published by PAGEPress Publications in European Journal of Translational Myology
- Vol. 35 (1)
Abstract
Hyperbaric oxygen therapy (HBOT) is a non-invasive method of O2 delivery that induces systemic hyperoxia. Hyperbaric chamber consists of a pressure vessel and a compressed breathing gas supply, which can regulate internal pressure. The chamber delivers 100% O2 to patients according to predetermined protocols and is monitored by trained personnel. HBOT relies on increasing the inspired O2 fraction (fiO2) and elevating the partial pressure of O2 (pO2). O2 is typically administered at pressures between 1.5 and 3.0 ATA for 60 to 120 minutes, depending on the clinical presentation. Currently, there are 15 indications for HBOT approved by the Undersea and Hyperbaric Medicine Society, categorized into three groups: emergency medicine, wound healing acceleration, and antimicrobial effects. The present narrative review aims to elucidate the mechanisms action underlying HBOT, particularly oxy-inflammation, in various pathologies within these categories.Keywords
This publication has 58 references indexed in Scilit:
- Prognostic factors for hearing outcomes in patients that undergo adjuvant hyperbaric oxygen therapy for sudden sensorineural hearing lossLaryngoscope Investigative Otolaryngology, 2022
- Hyperbaric Air Exposure at 2.5 ATA Does Not Affect Respiratory Mechanics and Lung Histology in the RatLung, 2014
- Endothelial injury in sepsisIntensive Care Medicine, 2013
- Hyperbaric Oxygen Therapy in Femoral Head NecrosisThe Journal of Arthroplasty, 2010
- Hyperbaric oxygenation alleviates MCAO-induced brain injury and reduces hydroxyl radical formation and glutamate releaseEuropean Journal of Applied Physiology, 2009
- Beneficial effects of the heme oxygenase-1/carbon monoxide system in patients with severe sepsis/septic shockIntensive Care Medicine, 2009
- Hyperbaric Oxygenation Ameliorates Indomethacin-Induced Enteropathy in Rats by Modulating TNF-α and IL-1β ProductionDigestive Diseases and Sciences, 2006
- Hyperbaric oxygen therapy for delayed onset muscle soreness and closed soft tissue injury2004
- Hyperbaric oxygen modulates antioxidant enzyme activity in rat skeletal musclesEuropean Journal of Applied Physiology, 2001
- Hyperbaric O 2 reduces intestinal ischemia-reperfusion-induced TNF-α production and lung neutrophil sequestrationEuropean Journal of Applied Physiology, 2001